9,137 Shares in Cameco Corporation $CCJ Bought by Osmosis Investment Management UK Ltd

Osmosis Investment Management UK Ltd purchased a new stake in shares of Cameco Corporation (NYSE:CCJFree Report) (TSE:CCO) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 9,137 shares of the basic materials company’s stock, valued at approximately $931,000.

Several other institutional investors have also added to or reduced their stakes in CCJ. Vanguard Group Inc. boosted its holdings in shares of Cameco by 1.5% during the fourth quarter. Vanguard Group Inc. now owns 18,059,335 shares of the basic materials company’s stock worth $1,653,639,000 after purchasing an additional 258,193 shares during the period. Capital World Investors grew its stake in shares of Cameco by 0.3% in the fourth quarter. Capital World Investors now owns 13,545,354 shares of the basic materials company’s stock worth $1,240,047,000 after purchasing an additional 41,430 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of Cameco by 15.6% in the fourth quarter. Van ECK Associates Corp now owns 6,292,995 shares of the basic materials company’s stock worth $575,771,000 after purchasing an additional 849,188 shares during the last quarter. Morgan Stanley increased its holdings in Cameco by 7.0% during the 4th quarter. Morgan Stanley now owns 4,978,333 shares of the basic materials company’s stock valued at $455,468,000 after purchasing an additional 323,693 shares during the period. Finally, Norges Bank purchased a new position in Cameco during the 4th quarter valued at about $443,265,000. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Cameco Price Performance

Shares of NYSE CCJ opened at $102.26 on Tuesday. Cameco Corporation has a fifty-two week low of $73.20 and a fifty-two week high of $135.24. The company has a 50 day simple moving average of $96.12 and a two-hundred day simple moving average of $107.24. The company has a market capitalization of $44.54 billion, a price-to-earnings ratio of 173.32, a P/E/G ratio of 1.75 and a beta of 1.05. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.10 and a current ratio of 3.06.

Cameco (NYSE:CCJGet Free Report) (TSE:CCO) last released its earnings results on Friday, July 31st. The basic materials company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.13). The business had revenue of $573.06 million for the quarter, compared to analysts’ expectations of $579.60 million. Cameco had a net margin of 10.20% and a return on equity of 7.59%. Cameco’s revenue for the quarter was down 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.71 earnings per share. Analysts expect that Cameco Corporation will post 1.27 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently commented on CCJ shares. Scotiabank reaffirmed an “outperform” rating and issued a $175.00 price target on shares of Cameco in a research note on Wednesday, May 6th. Royal Bank Of Canada boosted their price objective on shares of Cameco from $160.00 to $175.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. Sanford C. Bernstein restated an “outperform” rating and issued a $135.00 price objective on shares of Cameco in a report on Monday, June 15th. Citigroup reaffirmed a “positive” rating on shares of Cameco in a research report on Wednesday, July 15th. Finally, Wall Street Zen lowered shares of Cameco from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. Fourteen equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Cameco currently has a consensus rating of “Moderate Buy” and an average price target of $145.68.

Check Out Our Latest Report on CCJ

Cameco Company Profile

(Free Report)

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.

Read More

Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJFree Report) (TSE:CCO).

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.